Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Diagn Microbiol Infect Dis ; 105(2): 1-9, 2022.
Article in English | LILACS, CONASS, ColecionaSUS, SES-SP, SESSP-IALPROD, SES-SP | ID: biblio-1424922

ABSTRACT

We assessed the performance of MTBDRsl for detection of resistance to fluoroquinolones, aminoglycosides/cyclic peptides, and ethambutol compared to BACTEC MGIT 960 by subjecting simultaneously to both tests 385 phenotypically multidrug-resistant-Mycobacterium tuberculosis isolates from Sao Paulo, Brazil. Discordances were resolved by Sanger sequencing. MTBDRsl correctly detected 99.7% of the multidrug-resistant isolates, 87.8% of the pre-XDR, and 73.9% of the XDR. The assay showed sensitivity of 86.4%, 100%, 85.2% and 76.4% for fluoroquinolones, amikacin/kanamycin, capreomycin and ethambutol, respectively. Specificity was 100% for fluoroquinolones and aminoglycosides/cyclic peptides, and 93.6% for ethambutol. Most fluoroquinolone-discordances were due to mutations in genome regions not targeted by the MTBDRsl v. 1.0: gyrA_H70R and gyrB_R446C, D461N, D449V, and N488D. Capreomycin-resistant isolates with wild-type rrs results on MTBDRsl presented tlyA mutations. MTBDRsl presented good performance for detecting resistance to second-line drugs and ethambutol in clinical isolates. In our setting, multidrug-resistant. isolates presented mutations not targeted by the molecular assay.


Subject(s)
Amikacin , Sensitivity and Specificity , Genome , Diagnosis , Mycobacterium tuberculosis
2.
Rev. Soc. Bras. Med. Trop ; 53: e20190404, 2020. tab, graf
Article in English | SES-SP, ColecionaSUS, LILACS | ID: biblio-1136910

ABSTRACT

Abstract INTRODUCTION: We aimed to estimate the prevalence and transmission of drug-resistant tuberculosis in a high-burden Brazilian setting under directly observed therapy short-course strategy. METHODS: Isolates of culture-confirmed pulmonary tuberculosis patients from Guarulhos, Brazil, diagnosed in October 2007-2011 were subjected to drug susceptibility and IS6110-restriction fragment length polymorphism testing. RESULTS: The overall resistance prevalence was 11.5% and the multi-drug resistance rate was 4.2%. Twenty-six (43.3%) of 60 drug-resistant isolates were clustered. Epidemiological relationships were identified in 11 (42.3%) patients; 30.8% of the cases were transmitted in households. CONCLUSIONS: Drug-resistant tuberculosis was relatively low and transmitted in households and the community.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Young Adult , Polymorphism, Restriction Fragment Length , Brazil/epidemiology , Prevalence , Cross-Sectional Studies , Tuberculosis, Multidrug-Resistant , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Multidrug-Resistant/epidemiology , Directly Observed Therapy/methods , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/genetics
3.
J. bras. pneumol ; 45(2): e20180128, 2019. tab, graf
Article in English | LILACS | ID: biblio-1002440

ABSTRACT

ABSTRACT Objective: To evaluate the rapid diagnosis of multidrug-resistant tuberculosis, by using a commercial line probe assay for rifampicin and isoniazid detection (LPA-plus), in the routine workflow of a tuberculosis reference laboratory. Methods: The LPA-plus was prospectively evaluated on 341 isolates concurrently submitted to the automated liquid drug susceptibility testing system. Results: Among 303 phenotypically valid results, none was genotypically rifampicin false-susceptible (13/13; 100% sensitivity). Two rifampicin-susceptible isolates harboured rpoB mutations (288/290; 99.3% specificity) which, however, were non-resistance-conferring mutations. LPA-plus missed three isoniazid-resistant isolates (23/26; 88.5% sensitivity) and detected all isoniazid-susceptible isolates (277/277; 100% specificity). Among the 38 (11%) invalid phenotypic results, LPA-plus identified 31 rifampicin- and isoniazid-susceptible isolates, one isoniazid-resistant and six as non-Mycobacterium tuberculosis complex. Conclusions: LPA-plus showed excellent agreement (≥91%) and accuracy (≥99%). Implementing LPA-plus in our setting can speed up the diagnosis of multidrug-resistant tuberculosis, yield a significantly higher number of valid results than phenotypic drug susceptibility testing and provide further information on the drug-resistance level.


RESUMO Objetivo: Avaliar o diagnóstico rápido de tuberculose multirresistente, utilizando um teste comercial de sondas em linha (LPA-plus), na rotina de um laboratório de referência de tuberculose. Métodos: O teste LPA-plus foi avaliado prospectivamente em 341 isolados simultaneamente submetidos ao teste de suscetibilidade aos antimicrobianos em meio líquido, pelo sistema automatizado. Resultados: Entre os 303 resultados fenotipicamente válidos, nenhum foi genotipicamente falso suscetível à rifampicina (13/13; 100% de sensibilidade). Dois isolados sensíveis à rifampicina apresentavam mutações no gene rpoB (288/290; especificidade de 99,3%), as quais, no entanto, não são associadas à resistência a rifampicina. O LPA-plus não identificou resistência à isoniazida em três isolados fenotipicamente resistentes (23/26; 88,5% de sensibilidade) e detectou todos os isolados sensíveis à isoniazida (277/277; especificidade de 100%). Entre os 38 (11%) resultados fenotípicos inválidos, o LPA-plus identificou 31 isolados sensíveis à rifampicina e à isoniazida, um resistente à isoniazida e seis como micobactérias não tuberculosas. Conclusões: O LPA-plus mostrou excelente concordância (≥91%) e acurácia (≥99%). Sua implementação pode acelerar o diagnóstico da tuberculose multirresistente, produzir número significativamente maior de resultados válidos do que o teste fenotípico de suscetibilidade aos antimicrobianos e fornecer informações adicionais sobre o nível de resistência aos fármacos.


Subject(s)
Humans , Male , Female , Infant , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Phenotype , Rifampin/pharmacology , Time Factors , DNA, Bacterial , Microbial Sensitivity Tests , Prospective Studies , Reproducibility of Results , Sensitivity and Specificity , Tuberculosis, Multidrug-Resistant/diagnosis , Tuberculosis, Multidrug-Resistant/microbiology , Nucleic Acid Amplification Techniques/methods , Molecular Diagnostic Techniques/methods , Early Diagnosis , Isoniazid/pharmacology , Mycobacterium tuberculosis/isolation & purification , Mycobacterium tuberculosis/drug effects , Antitubercular Agents/pharmacology
4.
Mem. Inst. Oswaldo Cruz ; 110(6): 755-759, Sept. 2015. tab
Article in English | LILACS, SES-SP | ID: lil-763097

ABSTRACT

The aim of the present study was to assess the prevalence of Haemophilus influenzaetype b (Hib) nasopharyngeal (NP) colonisation among healthy children where Hib vaccination using a 3p+0 dosing schedule has been routinely administered for 10 years with sustained coverage (> 90%). NP swabs were collected from 2,558 children who had received the Hib vaccine, of whom 1,379 were 12-< 24 months (m) old and 1,179 were 48-< 60 m old. Hi strains were identified by molecular methods. Hi carriage prevalence was 45.1% (1,153/2,558) and the prevalence in the 12-< 24 m and 48-< 60 m age groups were 37.5% (517/1,379) and 53.9% (636/1,179), respectively. Hib was identified in 0.6% (16/2,558) of all children in the study, being 0.8% (11/1,379) and 0.4% (5/1,179) among the 12-< 24 m and 48-< 60 m age groups, respectively. The nonencapsulate Hi colonisation was 43% (n = 1,099) and was significantly more frequent at 48-< 60 m of age (51.6%, n = 608) compared with that at 12-< 24 m of age (35.6%, n = 491). The overall resistance rates to ampicillin and chloramphenicol were 16.5% and 3.7%, respectively; the co-resistance was detected in 2.6%. Our findings showed that the Hib carrier rate in healthy children under five years was very low after 10 years of the introduction of the Hib vaccine.


Subject(s)
Humans , Infant , Child, Preschool , Carrier State/immunology , Haemophilus Infections/prevention & control , Haemophilus Vaccines/therapeutic use , Haemophilus influenzae type b/immunology , Nasopharynx/microbiology , Ampicillin Resistance/immunology , Bacterial Capsules/immunology , Brazil/epidemiology , Carrier State/microbiology , Chloramphenicol Resistance/immunology , Cross-Sectional Studies , Haemophilus Infections/epidemiology , Haemophilus influenzae type b/classification , Immunization Schedule , Mass Vaccination , Microbial Sensitivity Tests , Polymerase Chain Reaction , Prevalence , Surveys and Questionnaires
5.
Rev. Inst. Adolfo Lutz (Online) ; 72(4): 288-294, 2013. tab, graf
Article in Portuguese | LILACS, SES-SP, SESSP-CTDPROD, SES-SP, SESSP-IALPROD, SES-SP | ID: lil-742461

ABSTRACT

As prevalências do HIV, da tuberculose (TB) e da coinfecção TB/HIV foram avaliadas no Sistema Prisional de Itirapina/SP (Penitenciárias I e II). Foi efetuado estudo retrospectivo dos registros dos exames realizados no IAL-Rio Claro no período de janeiro/2003 a dezembro/2010. A baciloscopia/cultura para TB foi realizada em 24,3 % (1.375 amostras) da PI e em 25, 9 % (3.332 amostras) da PII, e a sorologia para HIV, em 1.810 amostras da PI (32,0 %) e em 2.634 (20,4 %) da PII. Foram detectadas 157 culturas positivas para micobactérias (3,3 %), 177 amostras soropositivas para HIV (4,0 %), e 16 positivas para TB/HIV (11,5 %). A prevalência de TB foi de 2,8 % e 3,6 % (p=0,160), de HIV foi de 2,1 % e 5,3 %(p<0,001), respectivamente, para PI e PII; e a de coinfecção TB/HIV foi 0,4 % (p=0,744) em PI e PII. A soroprevalência de HIV nos indivíduos com TB foi de 13,2 % em PI e 9,2 % (p=0,487) em PII; a prevalência maior em PII sugere que o comportamento da doença difere com a característica populacional. Elevada prevalência de TB, HIV e coinfecção TB/HIV mostra a importância do diagnóstico destas infecções em todos os indivíduos no momento da admissão para definir as medidas de prevenção e de tratamentos dos internos e seus contatos.


HIV, tuberculosis (TB) and TB/HIV co-infection prevalences were assessed in prisons PI and PII inItirapina, SP, Brazil. This retrospective study was performed by consulting the records of diagnosticassays carried out at the Instituto Adolfo Lutz (IAL) Rio Claro Laboratory from January 2003 toDecember 2010. Culture for TB was performed on 24.3 % (1,375 samples) of PI and 25.8 % (3,332samples) of PII, and HIV serology in 32.0 % (1,810 samples) of PI and 20.4 % (2,634 samples) ofPII. There were 177 (4.0 %) HIV positive samples, 157 (3.3 %) positive culture for mycobacteria,and 16 (11.5 %) for TB/HIV. The prevalences of TB were 2.8 % and 3.6 % (p=0.160) for PI and PIIrespectively; of HIV, 2.1 % and 5.3 % (p<0.001) for PI and PII; and of TB/HIV co-infection, 0.4 %(p=0.744) for both PI and PII. Among TB patients, HIV prevalence was 13.2 % in PI and 9.2 %(p=0.487) in PII. Higher HIV prevalence in PII suggests that it depends on the population characteristics.The high prevalence rates of TB, HIV and TB/HIV show that it is crucial to perform the diagnostic testingin all of imprisoned individuals at admission to define the disease treatment and prevention measuresamong inmates and their contacts.


Subject(s)
Humans , HIV , Coinfection , Prevalence , Prisons , Tuberculosis/epidemiology , Brazil
6.
Rev. panam. salud pública ; 25(4): 305-313, abr. 2009. graf, tab
Article in Spanish | LILACS | ID: lil-515969
7.
Rev. Inst. Med. Trop. Säo Paulo ; 36(5): 475-8, set.-out. 1994. ilus, tab
Article in English | LILACS | ID: lil-154324

ABSTRACT

Com a finalidade de melhorar o diagnostico da leptospirose humana, padronizou-se o teste dot-ELISA para a pesquisa de anticorpos especificos da classe IgM na saliva. Empregaram-se amostras de saliva e soro coletadas simultaneamente de 20 pacientes com a forma icterohemorragica da doenca, de 10 pacientes com outras patologias e 5 controles negativos. Culturas de Leptospira em meio EMJH, dos sorovares: icterohaemorrhagiae, canicola, hebdomadis, brasiliensis e cynopteri, foram utilizadas como antigeno, na concentracao proteica individual de 0,2 ug/ul, misturadas em volumes iguais. Na fase solida do teste empregou-se tecido de poliester impregnado com resina de N-metilol-acrilamida....


Subject(s)
Immunoglobulin M/immunology , Leptospirosis/diagnosis , Saliva/microbiology , Immunoenzyme Techniques , Leptospirosis/blood , Resins, Synthetic/classification
8.
Mem. Inst. Oswaldo Cruz ; 82(1): 91-100, jan.-mar. 1987. tab, ilus
Article in Portuguese | LILACS | ID: lil-42732

ABSTRACT

Com o intuito de fornecer dados ao estudo da leptospirose humana, foram analisados 884 pacientes diagnosticados sorologicamente no Laboratório de Leptospirose da Fundaçäo Oswaldo Cruz - FIOCRUZ, no período de 1970 a 1982. Deste total, 775 estiveram internados em hospitais da cidade do Rio de Janeiro e 109 eram oriundos de outras cidades do Brasil. Sorologicamente, Icterohaemorrhagiae foi o sorogrupo mais freqüente, tanto para os pacientes do Grande Rio (76,4%), como para os demais (41,3%). No decorrer dos 13 anos, foram isoladas duas cepas de Icterohaemorrhagiae. Com relaçäo ao Grande Rio, observou-se uma freqüência maior da doença entre janeiro e abril (53,7%); o sexo masculino concorreu para 89,9% dos casos; e a faixa etária mais atingida compôs-se de indivíduos entre 16 e 45 anos (74,9%)


Subject(s)
Child , Adolescent , Adult , Middle Aged , Humans , Male , Female , Leptospirosis/epidemiology , Brazil
SELECTION OF CITATIONS
SEARCH DETAIL